A Novel Ovarian Reserve Monitoring Algorithm for Patients at Risk of Ovarian Injury From Gonadotoxic Therapy
NCT05048654 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-09-18
Summary
This is an observational cohort study to examine the use of a novel proposed ovarian reserve monitoring algorithm to (1) identify patients who are at risk of DOR and POI from gonadotoxic therapy, (2) minimize time from treatment to utilization of assisted reproductive technologies, and (3) improves prognosis for successful ART based on AFC for patients who pursue fertility or fertility preservation.
Conditions
- Ovarian Diseases
- Fertility Issues
- Gonadal Disorders
Sponsors & Collaborators
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Leslie Appiah, MD · University of Colorado, Denver
Eligibility
- Min Age
- 8 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-15
- Primary Completion
- 2028-12-31
- Completion
- 2029-06-30
More Related Trials
-
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT05440617 ·Status: RECRUITING
-
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient
NCT05847660 ·Status: UNKNOWN ·Phase: NA
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Biomarkers of Ovarian Reserve and Correlation With IVF Treatments
NCT02442895 ·Status: COMPLETED
-
DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT
NCT05847283 ·Status: RECRUITING ·Phase: NA
-
The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome
NCT00617864 ·Status: WITHDRAWN ·Phase: NA
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA
-
Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
NCT06879002 ·Status: NOT_YET_RECRUITING
-
Open, Non-comparative Pilot Study to Evaluate the Safety and Efficacy of Intraovarian Plasma Rich in Growth Factors (PRGF) in Patients With Low Ovarian Reserve
NCT06975683 ·Status: RECRUITING ·Phase: NA
-
AMH and Dosing Regimens for Initial IVF Stimulation Protocols
NCT03098199 ·Status: COMPLETED ·Phase: NA
-
Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
NCT03007043 ·Status: COMPLETED
-
Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUI
NCT02510534 ·Status: TERMINATED ·Phase: PHASE1
-
LATE LUTEAL PHASE VS. CONVENTIONAL EARLY FOLLICULAR PHASE START IN IVF
NCT06551376 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Salivary Diagnostic Testing for IVF
NCT02040545 ·Status: COMPLETED
-
GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
NCT01634724 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Fertility Treatments and Fertility Preservation
NCT04602962 ·Status: RECRUITING
-
Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program
NCT01009567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
NCT00954811 ·Status: UNKNOWN ·Phase: PHASE4
-
Diagnostic Value of Sperm DNA Fragmentation and Sperm Morphology for Assisted Reproduction Treatment
NCT02520869 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
NCT02827656 ·Status: UNKNOWN ·Phase: NA
-
Follicular Activation in Poor Responders
NCT02354963 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique
NCT05558046 ·Status: UNKNOWN
-
Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer
NCT02323347 ·Status: COMPLETED
-
Dual Trigger for Elective Fertility Preservation
NCT04992468 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response
NCT04168892 ·Status: COMPLETED